User profiles for K Dheda

Keertan Dheda

Professor, University of Cape Town & London School of Hygiene and Tropical Medicine
Verified email at uct.ac.za
Cited by 46590

Real-time RT-PCR normalisation; strategies and considerations

J Huggett, K Dheda, S Bustin, A Zumla - Genes & Immunity, 2005 - nature.com
Real-time RT-PCR has become a common technique, no longer limited to specialist core
facilities. It is in many cases the only method for measuring mRNA levels of vivo low copy …

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

K Dheda, T Gumbo, G Maartens, KE Dooley… - The lancet Respiratory …, 2017 - thelancet.com
Global tuberculosis incidence has declined marginally over the past decade, and tuberculosis
remains out of control in several parts of the world including Africa and Asia. Although …

Gamma interferon release assays for detection of Mycobacterium tuberculosis infection

…, A Cattamanchi, DW Dowdy, K Dheda… - Clinical microbiology …, 2014 - Am Soc Microbiol
Identification and treatment of latent tuberculosis infection (LTBI) can substantially reduce
the risk of developing active disease. However, there is no diagnostic gold standard for LTBI. …

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa …

…, R Colin-Jones, CL Cutland, TC Darton, K Dheda… - The Lancet, 2021 - thelancet.com
Background A safe and efficacious vaccine against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of …

[HTML][HTML] Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a …

…, AM Collins, CL Cutland, TC Darton, K Dheda… - The Lancet, 2021 - thelancet.com
Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency
use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, …

Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant

…, L Fairlie, SD Padayachee, K Dheda… - … England Journal of …, 2021 - Mass Medical Soc
Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …

Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant

…, M Tameris, N Singh, A Goga, K Dheda… - … England Journal of …, 2021 - Mass Medical Soc
Background The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …

Validation of housekeeping genes for normalizing RNA expression in real-time PCR

K Dheda, JF Huggett, SA Bustin, MA Johnson… - …, 2004 - Future Science
Analysis of RNA expression using techniques like real-time PCR has traditionally used
reference or housekeeping genes to control for error between samples. This practice is being …

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

NR Gandhi, P Nunn, K Dheda, HS Schaaf, M Zignol… - The Lancet, 2010 - thelancet.com
Although progress has been made to reduce global incidence of drug-susceptible
tuberculosis, the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) …

The clinical utility of urine lipoarabinomannan and the novel point-of-care lateral flow strip test (Determine® TB) for the diagnosis of tuberculosis in hospitalised …

…, L Mottay, S Kraus, R Meldau, K Dheda - C94. DETECTING …, 2011 - atsjournals.org
Methods: 316 hospitalised adults with suspected active TB and advanced HIV were enrolled.
Sputum smear microscopy, mycobacterial culture and HIV testing were performed where …